MLH1 Promotor Hypermethylation in Colorectal and Endometrial Carcinomas from Patients with Lynch Syndrome.

MLA

Helderman, Noah C., et al. “MLH1 Promotor Hypermethylation in Colorectal and Endometrial Carcinomas from Patients with Lynch Syndrome.” The Journal of Molecular Diagnostics : JMD, vol. 26, no. 2, Feb. 2024, pp. 106–14. EBSCOhost, https://doi.org/10.1016/j.jmoldx.2023.10.005.

APA

Helderman, N. C., Andini, K. D., van Leerdam, M. E., van Hest, L. P., Hoekman, D. R., Ahadova, A., Bajwa-Ten Broeke, S. W., Bosse, T., van der Logt, E. M. J., Imhann, F., Kloor, M., Langers, A. M. J., Smit, V. T. H. B. M., Terlouw, D., van Wezel, T., Morreau, H., & Nielsen, M. (2024). MLH1 Promotor Hypermethylation in Colorectal and Endometrial Carcinomas from Patients with Lynch Syndrome. The Journal of Molecular Diagnostics : JMD, 26(2), 106–114. https://doi.org/10.1016/j.jmoldx.2023.10.005

Chicago

Helderman, Noah C, Katarina D Andini, Monique E van Leerdam, Liselotte P van Hest, Daniël R Hoekman, Aysel Ahadova, Sanne W Bajwa-Ten Broeke, et al. 2024. “MLH1 Promotor Hypermethylation in Colorectal and Endometrial Carcinomas from Patients with Lynch Syndrome.” The Journal of Molecular Diagnostics : JMD 26 (2): 106–14. doi:10.1016/j.jmoldx.2023.10.005.